Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Enanta Pharmaceuticals Inc. buy BiotechBee

Start price
€7.65
28.09.25 / 70%
Target price
€10.00
30.09.27
Performance (%)
20.92%
End price
€9.25
18.10.25
Summary
This prediction ended on 18.10.25 with a price of €9.25. The prediction had a final performance of 20.92%. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m
Enanta Pharmaceuticals Inc. -4.065% -4.065%
iShares Core DAX® 0.734% -0.964%
iShares Nasdaq 100 -2.686% -2.409%
iShares Nikkei 225® -2.261% -4.038%
iShares S&P 500 -1.346% -1.510%

According to BiotechBee what are the pros and cons of Enanta Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Enanta Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 20.92%
Target price 10.000
Change
Ends at 30.09.27

Buy mit Kursziel 10,0

In the thread Trading Enanta Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 20.92%
Target price 10.000
Change
Ends at 30.09.27

Buy beendet

Stopped prediction by BiotechBee for Enanta Pharmaceuticals Inc.

buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.30
16.09.24
€18.00
28.02.27
-41.26%
14.12.24

Could be very worthwhile Investment >20% year
buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.60
11.01.23
€60.00
31.12.25
-30.47%
05.05.23

Could be very worthwhile Investment >20% year